Resources

To manage the spread and control the pandemic, regular COVID-19 testing along with vaccination are critical behaviors to drive in the population, where supply and demand side issues need to be managed side by side. However, much of the discussion, policy and efforts in India are limited to supply of testing, and supply/logistics of vaccines, while the issue of people’s demand for testing and confidence in vaccines and willingness to get vaccinated is not being adequately addressed.While survey data and other studies are important to understanding overall hesitancy, there is a need for a behavioural science and HCD-led approach to identify strategic levers which can be used to design the communication campaign and service delivery design for vaccine rollout.

The Global Fund Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.The 2020-2021 Annual Report presents findings from the grant cycle analysis which examined what, when, why, and how grants approved through the New Funding Model 2 (NFM2; 2017-2019 funding cycle) changed over time, including significant factors that influenced the implementation of changes to the original grant. Additionally, the report includes findings on how the NFM3 (2020-2022 funding cycle) grant design process was informed by lessons from NFM2.The 2021 Extension Phase Report presents findings from a three-month extension of the PCE that focused on a deeper analysis of several areas within the grant cycle analysis, including: grant revision and lessons learnt from the Global Fund’s response to COVID-19, investments in health systems support and health systems strengthening, uptake of new RSSH coverage indicators, and drivers of budgetary shifts in RSSH and equity-related investments during NFM3 grant making.

The Global Fund Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.The 2020-2021 Annual Report presents findings from the grant cycle analysis which examined what, when, why, and how grants approved through the New Funding Model 2 (NFM2; 2017-2019 funding cycle) changed over time, including significant factors that influenced the implementation of changes to the original grant. Additionally, the report includes findings on how the NFM3 (2020-2022 funding cycle) grant design process was informed by lessons from NFM2.The 2021 Extension Phase Report presents findings from a three-month extension of the PCE that focused on a deeper analysis of several areas within the grant cycle analysis, including: grant revision and lessons learnt from the Global Fund’s response to COVID-19, investments in health systems support and health systems strengthening, uptake of new RSSH coverage indicators, and drivers of budgetary shifts in RSSH and equity-related investments during NFM3 grant making.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2020 presenting a comprehensive look at the Global Fund grant cycle. The PCE assessed how business model factors have facilitated or hindered the achievement of objectives during implementation of grants approved during the 2017-19 funding cycle, including around Resilient and Sustainable Systems for Health (RSSH), sustainability and equity, and whether lessons learned during current grants have informed the next funding cycle. The objective of this grant cycle analysis was to understand what, when, why, and how grant investments change over time, including significant factors that influenced the implementation of and changes to the original grant.

As the COVID-19 pandemic continues, there is an urgent need to maintain the delivery and quality of essential health services. Many national and subnational governments have been actively developing policies, strategies, and guidelines related to the maintenance, adaptation, or discontinuation of health services. PATH, at the request of WHO and with support from the Bill & Melinda Gates Foundation, is rapidly collecting national and subnational policy materials related to the provision of essential health services during COVID-19, with the objectives of describing government responses across health services and over time; comparing government responses to WHO’s operational guidance on maintaining essential health services, and to responses of peer countries; and identifying gaps in responses to help target technical assistance, monitoring, evaluation, research, and learning.This document reports interim findings of this project as of October 2020. The first version of the Policy Tracker database is publicly available here.